GlassScriptPhysician profile
Amir Iqbal Choudhry
NPI 1457388258
$9,481.45
in general payments reported to CMS, 2019-2025
42 companies · $655 in 2025
The $655 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,728 · 2020: $527 · 2021: $1,764 · 2022: $2,342 · 2023: $1,449 · 2024: $1,016 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,119.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,128.72 | 2019-2025 | Jot Dx, Ensite, Aveir |
| Novartis Pharmaceuticals Corporation | $1,130.70 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $652.62 | 2019-2023 | Xarelto |
| Medtronic, INC. | $574.87 | 2021-2025 | Symplicity G3 |
| Merck Sharp & Dohme LLC | $489.39 | 2021-2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $385.55 | 2019-2025 | Camzyos, Eliquis |
| Heartflow, INC. | $373.75 | 2019-2025 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $368.45 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $365.97 | 2019-2024 | |
| Itamar Medical INC | $311.03 | 2022-2023 | Watchpatone |
| Amarin Pharma, INC. | $306.87 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $286.25 | 2019-2024 | Jardiance |
| Alnylam Pharmaceuticals INC. | $257.29 | 2021-2023 | Onpattro |
| Amgen INC. | $254.46 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $212.50 | 2019-2024 | Farxiga |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $171.69 | 2019 | |
| Cleerly, INC. | $131.65 | 2024-2025 | Cleerly Labs, Cleerly Ischemia |
| Novo Nordisk INC | $103.69 | 2021-2025 | Ozempic |
| Tactile Systems Technology INC | $97.80 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $87.26 | 2019-2022 | |
| Cvrx, INC. | $81.23 | 2022-2024 | Barostim Neo System |
| Astellas Pharma US INC | $77.66 | 2019-2020 | |
| Esperion Therapeutics, INC. | $73.36 | 2020-2023 | Nexletol |
| Kiniksa Pharmaceuticals, LTD. | $69.18 | 2021 | |
| Lundbeck LLC | $52.38 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $50.84 | 2019-2025 | Evkeeza |
| Actelion Pharmaceuticals US, INC. | $44.96 | 2020-2024 | Uptravi, Opsumit |
| Recor Medical INC | $38.63 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Baxter Healthcare | $36.12 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Edwards Lifesciences Corporation | $32.17 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Scpharmaceuticals INC. | $28.46 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $26.68 | 2024 | Arcalyst |
| Althera Pharmaceuticals LLC | $26.59 | 2022 | |
| Bardy Diagnostics, INC. | $26.00 | 2021 | |
| Innovation Technologies INC | $23.82 | 2023 | Irrisept |
| Kowa Pharmaceuticals America, INC. | $16.07 | 2020 | |
| Inspire Medical Systems, INC. | $15.20 | 2024 | Inspire |
| Cardiva Medical, INC. | $15.11 | 2019 | |
| Saranas, INC. | $14.78 | 2022 | |
| Azurity Pharmaceuticals, INC. | $14.53 | 2024 | Edarbyclor |
| Surmodics, INC. | $14.12 | 2024 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| G Medical Diagnostic Services, INC. | $13.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Choudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.